KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Molina Healthcare (MOH) Research & Development (2016 - 2018)

Molina Healthcare's Research & Development history spans 9 years, with the latest figure at $120.0 million for Q1 2018.

  • For Q1 2018, Research & Development fell 1.64% year-over-year to $120.0 million; the TTM value through Mar 2018 reached $489.0 million, up 1.88%, while the annual FY2017 figure was $492.0 million, 1.44% up from the prior year.
  • Research & Development for Q1 2018 was $120.0 million at Molina Healthcare, down from $124.0 million in the prior quarter.
  • Across five years, Research & Development topped out at $127.0 million in Q1 2016 and bottomed at $32.8 million in Q2 2015.
  • The 5-year median for Research & Development is $89.6 million (2015), against an average of $80.1 million.
  • The largest annual shift saw Research & Development decreased 13.71% in 2015 before it soared 253.45% in 2016.
  • A 5-year view of Research & Development shows it stood at $39.2 million in 2014, then soared by 128.77% to $89.6 million in 2015, then surged by 37.26% to $123.0 million in 2016, then grew by 0.81% to $124.0 million in 2017, then fell by 3.23% to $120.0 million in 2018.
  • Per Business Quant, the three most recent readings for MOH's Research & Development are $120.0 million (Q1 2018), $124.0 million (Q2 2017), and $122.0 million (Q1 2017).